Developer docs
API playgroundTry for free, no card

Search company profiles

PneumRx

Full company profile

uuid0007zz9

Namestring
PneumRx
Legal namestring
Boston Scientific Corporation
Websiteurl
pneumrx.com
Company typeenum
Public
Founded yearint
2004
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersMountain View, United States
HQ citystring
Mountain View
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
interventional pulmonology devices, pulmonary medical devices, minimally-invasive lung devices, respiratory therapeutics, lung disease treatments
Industry2 codes
1Pulmonary Function Testing (PFT) & Respiratory Diagnostics
CodeHLAKANACPrimaryYes
2Pulmonary Function Testing (PFT) & Spirometry Equipment
CodeHLAHAGAHPrimaryNo
NAICS code1 code
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Interventional Pulmonology Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Medical Device Sales
TypeHardware Sales
Description

Boston Scientific generates revenue primarily through the sale of medical devices across multiple specialty areas including cardiovascular, endoscopy, neuromodulation, and urology. Products include implants, disposables, and capital equipment sold to hospitals and healthcare providers.

bostonscientific.com
2Professional Services and Training
TypeProfessional Services
Description

Revenue generated through medical education programs (EDUCARE), professional training, and clinical support services provided to healthcare professionals using Boston Scientific products.

bostonscientific.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Supply Chain, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

PneumRx is a medical device company that develops minimally-invasive solutions for unmet medical needs in pulmonary medicine. The company focuses on interventional devices used by pulmonologists and thoracic specialists to treat respiratory and lung conditions. Since 2019, PneumRx has operated as a wholly-owned subsidiary of Boston Scientific Corporation, contributing pulmonology and respiratory care capabilities to the parent's broader specialty device portfolio.

Differentiator
Functional benefit
Problem solved
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EDUCARE is Boston Scientific's medical education and training platform that collaborates with medical institutions and professional societies to provide continuing medical education and clinical training for healthcare professionals using Boston Scientific products.

2Healthcare Systems and Group Purchasing Organizations
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Boston Scientific works with healthcare systems and GPOs to make products available through contracted procurement relationships, enabling broad access to medical devices across hospital networks.

bostonscientific.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cook Medical manufactures interventional pulmonary devices including stents and airway management products, overlapping with PneumRx in the interventional pulmonology procedural toolkit and hospital procurement cycles.

TypeBroad incumbent
Description

Pentax Medical / HOYA provides bronchoscopy and pulmonary endoscopy capital equipment and disposables, comparable to PneumRx's downstream clinical setting and overlapping with the pulmonology specialty within Boston Scientific.

TypeDirect peer
Description

Spiration's endobronchial valve system, now part of Olympus, competes directly with PneumRx in the interventional lung volume reduction category, targeting the same severe emphysema patient population with a similar minimally-invasive approach.

TypeBroad incumbent
Description

Medtronic operates a diversified interventional pulmonology and respiratory portfolio (including superDimension navigation and related bronchoscopy tools) and is a broad incumbent that overlaps with PneumRx in the interventional pulmonary care pathway.

TypeBroad incumbent
Description

Intuitive's Ion robotic-assisted bronchoscopy platform targets diagnostic and therapeutic lung procedures, overlapping with PneumRx in the interventional pulmonology procedure workflow and competing for the same hospital capital budgets.

TypeDirect peer
Description

Pulmonx (NASDAQ: LUNG) markets the Zephyr Endobronchial Valve, the leading interventional device for lung volume reduction in severe emphysema/COPD — a direct competitor to PneumRx's coil-based technology in the same patient population, procedure setting, and payer environment.

TypeEmerging player
Description

CSA Medical develops the RejuvenAir system for chronic bronchitis and has historically explored cryotherapy for COPD — an emerging player in the same interventional pulmonary medicine niche as PneumRx.

TypeEmerging player
Description

Broncus Medical is an emerging interventional pulmonology company focused on lung navigation, biopsy, and COPD treatments — overlapping with PneumRx in targeting COPD via minimally-invasive bronchoscopic approaches.

TypeBroad incumbent
Description

Olympus is a broad incumbent in pulmonology and respiratory endoscopy through its bronchoscopy and EBUS platforms, and now houses the Spiration valve franchise — overlapping with PneumRx across interventional pulmonology procedures and channels.

TypeBroad incumbent
Description

J&J's Ethicon and Auris Health (Monarch platform) franchises offer robotic bronchoscopy and pulmonary ablation technologies that intersect with PneumRx's interventional pulmonology focus, making J&J a broad incumbent comparable in the same procedural specialty.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PneumRx

Interventional Pulmonology Devicespneumrx.com

PneumRx firmographics

Firmographics
Name
PneumRx
Legal name
Boston Scientific Corporation
Website
https://pneumrx.com
Company type
Public
Founded year
2004
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

PneumRx industry classification

Industry
Product category
Interventional Pulmonology Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Pulmonary Function Testing (PFT) & Respiratory Diagnostics (HLAKANAC)
akta.pro secondary industry
Pulmonary Function Testing (PFT) & Spirometry Equipment (HLAHAGAH)

Keywords

  • Interventional pulmonology devices
  • Pulmonary medical devices
  • Minimally-invasive lung devices
  • Respiratory therapeutics
  • Lung disease treatments

Where PneumRx is headquartered

Location

Headquarters

HQ city
Mountain View
HQ country
United States
HQ region
North America

Markets served

PneumRx business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations

Revenue model

  1. Medical Device Sales: Boston Scientific generates revenue primarily through the sale of medical devices across multiple specialty areas including cardiovascular, endoscopy, neuromodulation, and urology. Products include implants, disposables, and capital equipment sold to hospitals and healthcare providers.
  2. Professional Services and Training: Revenue generated through medical education programs (EDUCARE), professional training, and clinical support services provided to healthcare professionals using Boston Scientific products.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

PneumRx product offering

Product offering

Core offering

PneumRx is a medical device company that develops minimally-invasive solutions for unmet medical needs in pulmonary medicine. The company focuses on interventional devices used by pulmonologists and thoracic specialists to treat respiratory and lung conditions. Since 2019, PneumRx has operated as a wholly-owned subsidiary of Boston Scientific Corporation, contributing pulmonology and respiratory care capabilities to the parent's broader specialty device portfolio.

Differentiator

Problem solved

Functional benefit

Companies that use PneumRx

Customer profile

Named customers4 records

Segments2 records

Ideal customer profiles1 record

PneumRx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

PneumRx partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • EDUCARE Partners (Medical Education Institutions)coreStrategic or Co-development PartnerEDUCARE is Boston Scientific's medical education and training platform that collaborates with medical institutions and professional societies to provide continuing medical education and clinical training for healthcare professionals using Boston Scientific products.
  • Healthcare Systems and Group Purchasing OrganizationscoreChannel Partner/ Reseller/ DistributorBoston Scientific works with healthcare systems and GPOs to make products available through contracted procurement relationships, enabling broad access to medical devices across hospital networks.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

PneumRx competitors and assessment

Company assessment

Broad incumbents

  • Cook Medical: Cook Medical manufactures interventional pulmonary devices including stents and airway management products, overlapping with PneumRx in the interventional pulmonology procedural toolkit and hospital procurement cycles.
  • Pentax Medical (HOYA): Pentax Medical / HOYA provides bronchoscopy and pulmonary endoscopy capital equipment and disposables, comparable to PneumRx's downstream clinical setting and overlapping with the pulmonology specialty within Boston Scientific.
  • Medtronic: Medtronic operates a diversified interventional pulmonology and respiratory portfolio (including superDimension navigation and related bronchoscopy tools) and is a broad incumbent that overlaps with PneumRx in the interventional pulmonary care pathway.
  • Intuitive Surgical: Intuitive's Ion robotic-assisted bronchoscopy platform targets diagnostic and therapeutic lung procedures, overlapping with PneumRx in the interventional pulmonology procedure workflow and competing for the same hospital capital budgets.
  • Olympus Corporation: Olympus is a broad incumbent in pulmonology and respiratory endoscopy through its bronchoscopy and EBUS platforms, and now houses the Spiration valve franchise — overlapping with PneumRx across interventional pulmonology procedures and channels.
  • Johnson & Johnson (Ethicon / Auris Health): J&J's Ethicon and Auris Health (Monarch platform) franchises offer robotic bronchoscopy and pulmonary ablation technologies that intersect with PneumRx's interventional pulmonology focus, making J&J a broad incumbent comparable in the same procedural specialty.

Direct peers

  • Spiration (Olympus): Spiration's endobronchial valve system, now part of Olympus, competes directly with PneumRx in the interventional lung volume reduction category, targeting the same severe emphysema patient population with a similar minimally-invasive approach.
  • Pulmonx Corporation: Pulmonx (NASDAQ: LUNG) markets the Zephyr Endobronchial Valve, the leading interventional device for lung volume reduction in severe emphysema/COPD — a direct competitor to PneumRx's coil-based technology in the same patient population, procedure setting, and payer environment.

Emerging players

  • CSA Medical: CSA Medical develops the RejuvenAir system for chronic bronchitis and has historically explored cryotherapy for COPD — an emerging player in the same interventional pulmonary medicine niche as PneumRx.
  • Broncus Medical: Broncus Medical is an emerging interventional pulmonology company focused on lung navigation, biopsy, and COPD treatments — overlapping with PneumRx in targeting COPD via minimally-invasive bronchoscopic approaches.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

PneumRx social profiles

Digital presence

PneumRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PneumRx leadership team

Management profile

Number of profiles

Profiles2 records

PneumRx subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PneumRx funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PneumRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PneumRx

What does PneumRx do?

PneumRx is a medical device company that develops minimally-invasive solutions for unmet medical needs in pulmonary medicine. The company focuses on interventional devices used by pulmonologists and thoracic specialists to treat respiratory and lung conditions. Since 2019, PneumRx has operated as a wholly-owned subsidiary of Boston Scientific Corporation, contributing pulmonology and respiratory care capabilities to the parent's broader specialty device portfolio.

Is PneumRx a public or private company?

PneumRx is a public company. It is classified as corporate owned and is currently operating.

When was PneumRx founded?

PneumRx was founded in 2004. It employs 501 to 1,000 people.

Where is PneumRx based?

PneumRx is headquartered in Mountain View, United States, in the North America region.

How does PneumRx make money?

Two revenue lines are on record. Medical Device Sales are the primary driver. The others are professional Services and Training.

Who are PneumRx's main competitors?

Broad incumbents on record are Cook Medical, Pentax Medical (HOYA), Medtronic, Intuitive Surgical, Olympus Corporation and Johnson & Johnson (Ethicon / Auris Health). Direct peers are Spiration (Olympus) and Pulmonx Corporation. Emerging players are CSA Medical and Broncus Medical.

Does PneumRx have an API?

No public API is recorded for PneumRx.

What industry is PneumRx in?

PneumRx's product category is Interventional Pulmonology Devices. Its primary akta.pro industry code is HLAKANAC, Pulmonary Function Testing (PFT) & Respiratory Diagnostics, with a secondary code of HLAHAGAH, Pulmonary Function Testing (PFT) & Spirometry Equipment. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals